 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| MJNA Discusses Progress in Several Key Areas in New Audio Interview |
|
 Hot Stock to Watch
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
End of Day:
Price: 0.045
Change (%): + 0.005 (10.00)
Volume: 10,864,177 |
 |
A New Audio Interview with Dr. Stuart Titus, President and Chief Executive Officer of Medical Marijuana, Inc., is now at SmallCapVoice.com
AUSTIN, Texas, July 27, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) and SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with Medical Marijuana, Inc., a leading industrial hemp innovator, is now available. The interview can be heard at http://smallcapvoice.com/blog/7-20-15-smallcapvoice-interview-with-medical-marijuana-inc-mjna.
Stuart W. Titus, PhD, President and CEO of Medical Marijuana Inc. called into SmallCapVoice.com to provide the listening audience with his personal insights into the Company's recent news regarding their efforts in Brazil, their help with the path to legalization in Puerto Rico, the validation for the Company's top cannabis products from one of the top cannabis testing labs, ProVerde Labs. In addition, Dr. Titus gave a comprehensive progress report on the efforts of AXIM. Recently MJNA announced that they hold 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies (AXIM), a cutting-edge biotechnology innovator.
Continue Reading
|
 Yesterday's Top Performer
|
Company: PositiveID Corporation (OTCQB: PSID)
|
End of Day:
Price: 0.0244
Change (%): + 0.0008 (3.39)
Volume: 1,935,730 |
 |
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples.
Company Information Sheet |
Other Small Cap News
|
Company: Auxilio, Inc. (OTCQB: AUXO)
|
Auxilio Signs Five-Year 16 Million Dollar Managed Print Services Contract With Yale-New Haven Health System
Contract Services Over 300 Locations in the Northeast
MISSION VIEJO, CA--(Marketwired - Jul 27, 2015) - Auxilio, Inc. (OTCQB: AUXO), a leading provider of Managed Print Services (MPS) and IT Security for the healthcare industry, announced today a five-year, 16 million dollar contract for Managed Print Services with Yale-New Haven Health System (YNHHS).
YNHHS, the largest in Connecticut, includes three delivery networks: Bridgeport Hospital, Greenwich Hospital and Yale-New Haven Hospital. YNHH was the only Connecticut hospital to be nationally ranked by U.S. News & World Report's 2015-16 list of top U.S. hospitals.
Continue Reading
|
Company: NewLead Holdings Ltd. (OTC: NEWL)
|
NewLead Holdings Announces Commercial Competency of MT Sofia
HAMILTON, Bermuda, July 27, 2015 /PRNewswire/ -- NewLead Holdings Ltd. (OTC: NEWL) ("NewLead" or the "Company") announced today a review of the commercial competency of one of its bitumen tanker vessels, the MT Sofia ("Sofia") since the vessel was delivered to NewLead's fleet.
The Sofia is a 2008-built bitumen tanker vessel of 2,888 dwt and is one of the five bitumen tanker vessels that were delivered to NewLead's fleet during the fourth quarter of 2014.
Continue Reading
|
Company: TapImmune, Inc. (OTCQB: TPIV)
|
TapImmune Announces Finalization of License Agreement With Mayo Clinic To Commercialize a Folate Receptor Alpha Vaccine for Multiple Cancer Indications
SEATTLE, July 27, 2015 /PRNewswire/ -- TapImmune, Inc. (OTCQB: TPIV), a clinical stage cancer immunotherapy company, is pleased to announce that the Company has exercised its option agreement with Mayo Clinic. TapImmune has signed a worldwide exclusive license agreement to commercialize a proprietary folate receptor alpha vaccine technology for all cancer indications. This technology, developed in the laboratory of Keith Knutson, Ph.D., at Mayo, has successfully completed Phase I clinical trials in ovarian and triple-negative breast cancer.
TapImmune recently announced positive Phase 1 clinical data from the Folate Receptor Alpha trial in triple negative breast and ovarian cancer. The trial demonstrated the experimental therapy was safe, well-tolerated, provided a robust immune response, therefore, TapImmune plans to initiate a Phase II clinical trial in triple negative breast cancer during the second half of 2015. Under the license agreement the IND covering the clinical trial will be transferred to TapImmune.
Continue Reading |
Market News
|
By Evelyn Cheng : CNBC
|
Dow falls 150 points, Nasdaq off 1% as China, commodity slide weigh
U.S. stocks opened lower on Monday as the continued selloff in commodities and an overnight plunge in Shanghai stocks pressured sentiment amid a lackluster earnings season.
The Dow Jones industrial average briefly fell more than 150 points as nearly all the blue chips declined. The Nasdaq Composite fell more than 1 percent.
"China's already happened so there's nothing more to happen out of China today," said James Meyer, chief investment officer at Tower Bridge Advisors. "What you're going to watch today is commodities and earnings. It's the biggest week in S&P earnings this week."
Continue Reading
|
By Peter Schacknow: CNBC
|
Early movers: AGN, MYL, MHFI, UBS, FCAU, QCOM & more
Check out which companies are making headlines before the bell:
Allergan - Allergan announced a deal to sell its generic drugs unit to Teva Pharmaceuticals for 40.5 billion dollars in cash and stock. In a concurrent announcement, Teva said it had withdrawn its proposal to buy generic drug maker Mylan.
Mylan - Mylan responded to the Teva/Allergan announcement by congratulating Teva, and adding that it was looking forward to completing its own proposed deal to buy store-branded drug maker Perrigo.
McGraw Hill Financia - The parent of Standard and Poor's announced a deal to buy SNL Financial for 2.225 billion dollars in cash. SNL specializes in data and analytic services for the financial industry.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
 |
|
|
